Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : J...
Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)
About this item
Full title
Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)
Author / Creator
Ohlmann, C-H , Miller, K and Gschwend, J
Publisher
Germany
Journal title
Urologe. Ausgabe A, 2017-09, Vol.56 (9), p.1185-1186
Language
German
Formats
Publication information
Publisher
Germany
Subjects
More information
Alternative Titles
Full title
Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1922509986
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1922509986
Other Identifiers
E-ISSN
1433-0563
DOI
10.1007/s00120-017-0464-7
